Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Chakos

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The American Journal of Psychiatry|May 1, 1991
Real-life basis for a patient's paranoiaD Mayerhoff, E Pelta, C Valentino, et al.
The Psychiatric Clinics of North America|April 29, 1998
Emerging roles for novel antipsychotic medications in the treatment of schizophreniaC Andersson, M Chakos, R Mailman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 1, 1997
The behavioral effect of m-chlorophenylpiperazine (mCPP) and methylphenidate in first-episode schizophrenia and normal controlsA R Koreen, J A Lieberman, J Alvir, et al.
The American Journal of Psychiatry|April 3, 2001
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trialsM Chakos, J Lieberman, E Hoffman, et al.
Psychopharmacology Bulletin|January 1, 1993
Possible predictors of neuroleptic-resistant schizophrenic relapse: influence of negative symptoms and acute extrapyramidal side effectsB J Kinon, J M Kane, M Chakos, et al.
Journal of Clinical Psychopharmacology|April 29, 1998
The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspectiveJ A Lieberman, B Sheitman, M Chakos, et al.
Biological Psychiatry|March 21, 2001
Longitudinal study of brain morphology in first episode schizophreniaJ Lieberman, M Chakos, H Wu, et al.
The American Journal of Psychiatry|November 1, 1993
Depression in first-episode schizophreniaA R Koreen, S G Siris, M Chakos, et al.
The American Journal of Psychiatry|January 1, 1994
Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patientsA R Koreen, J Lieberman, J Alvir, et al.
Biological Psychiatry|December 18, 2001
The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approachesJ A Lieberman, D Perkins, A Belger, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The American Journal of Psychiatry|May 1, 1991
Real-life basis for a patient's paranoiaD Mayerhoff, E Pelta, C Valentino, et al.
The Psychiatric Clinics of North America|April 29, 1998
Emerging roles for novel antipsychotic medications in the treatment of schizophreniaC Andersson, M Chakos, R Mailman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 1, 1997
The behavioral effect of m-chlorophenylpiperazine (mCPP) and methylphenidate in first-episode schizophrenia and normal controlsA R Koreen, J A Lieberman, J Alvir, et al.
The American Journal of Psychiatry|April 3, 2001
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trialsM Chakos, J Lieberman, E Hoffman, et al.
Psychopharmacology Bulletin|January 1, 1993
Possible predictors of neuroleptic-resistant schizophrenic relapse: influence of negative symptoms and acute extrapyramidal side effectsB J Kinon, J M Kane, M Chakos, et al.
Journal of Clinical Psychopharmacology|April 29, 1998
The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspectiveJ A Lieberman, B Sheitman, M Chakos, et al.
Biological Psychiatry|March 21, 2001
Longitudinal study of brain morphology in first episode schizophreniaJ Lieberman, M Chakos, H Wu, et al.
The American Journal of Psychiatry|November 1, 1993
Depression in first-episode schizophreniaA R Koreen, S G Siris, M Chakos, et al.
The American Journal of Psychiatry|January 1, 1994
Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patientsA R Koreen, J Lieberman, J Alvir, et al.
Biological Psychiatry|December 18, 2001
The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approachesJ A Lieberman, D Perkins, A Belger, et al.
Pageof 3